Shang Chun-Yang, Sun Xue-Pu, Dong Xue-Song, Wang Yang-Shuai, Chen Xiao, Qiao Hai-Quan
Department of Gastrosplenic Surgery, Harbin Medical University, Harbin, 150000, China.
Curr Med Sci. 2025 Apr 30. doi: 10.1007/s11596-025-00052-0.
Peritoneal carcinomatosis (PC) is a common pattern of recurrence in gastric cancer patients and is associated with a poor prognosis. This study aimed to evaluate the predictive value of the albumin-fibrinogen ratio (AFR) for PC in patients with gastric cancer and to develop two preoperative prediction models.
A total of 745 gastric cancer patients were included in this study. Preoperative AFR, along with other serum markers and clinical tumor characteristics, was assessed. Univariate and multivariate logistic regression analyses were performed to determine the odds ratios (ORs) and 95% confidence intervals (CIs) of the independent variables. Propensity score matching (PSM) was used to control for potential confounders, and one-way ANOVA was conducted to evaluate differences in distribution between groups. Two prediction models incorporating the independent predictive indicators were constructed and validated via receiver operating characteristic (ROC) curves.
Poorly differentiated type (OR 2.679; P = 0.001), nondiffuse morphological type (OR 2.123; P = 0.040), BMI < 23.550 kg/m (OR 4.635; P = 0.001), AFR < 11.275 (OR 2.895; P = 0.003) and CA199 ≥ 73.615 U/mL (OR 2.040; P = 0.037) were identified as independent risk factors for PC in patients with gastric cancer. After PSM, the AFR remained the only inflammatory marker that was independently associated with PC (P = 0.003). AFR demonstrated consistent robustness in predicting PC across multiple sample sets. Among all the independent risk factors, the AFR had the highest area under the curve (AUC) for ROC analysis (AUC 0.648; 95% CI 0.580-0.715). Two combination models incorporating the AFR demonstrated enhanced predictive ability: Combination Model 1 (AUC 0.759; 95% CI 0.699-0.820) and Combination Model 2 (AUC 0.801; 95% CI 0.744-0.859).
The preoperative AFR serves as a useful indicator for predicting PC. Two reliable prediction models based on the AFR have been developed.
腹膜癌病(PC)是胃癌患者常见的复发模式,且与预后不良相关。本研究旨在评估白蛋白-纤维蛋白原比值(AFR)对胃癌患者PC的预测价值,并建立两种术前预测模型。
本研究共纳入745例胃癌患者。评估术前AFR以及其他血清标志物和临床肿瘤特征。进行单因素和多因素逻辑回归分析以确定自变量的比值比(OR)和95%置信区间(CI)。采用倾向评分匹配(PSM)来控制潜在混杂因素,并进行单因素方差分析以评估组间分布差异。构建包含独立预测指标的两种预测模型,并通过受试者工作特征(ROC)曲线进行验证。
低分化类型(OR 2.679;P = 0.001)、非弥漫形态类型(OR 2.123;P = 0.040)、BMI < 23.550 kg/m(OR 4.635;P = 0.001)、AFR < 11.275(OR 2.895;P = 0.003)和CA199≥�3.615 U/mL(OR 2.040;P = 0.037)被确定为胃癌患者PC的独立危险因素。PSM后,AFR仍然是唯一与PC独立相关的炎症标志物(P = 0.003)。AFR在多个样本集中预测PC时表现出一致的稳健性。在所有独立危险因素中,AFR在ROC分析中的曲线下面积(AUC)最高(AUC 0.648;95% CI 0.580 - 0.715)。包含AFR的两种组合模型显示出增强的预测能力:组合模型1(AUC 0.759;95% CI 0.699 - 0.820)和组合模型2(AUC 0.801;95% CI 0.744 - 0.859)。
术前AFR是预测PC的有用指标。基于AFR建立了两种可靠的预测模型。